|
| 1 |
Clinical Trials for Generation of Bridging Data Do we Need "Koreans only" Additional Phase III Trials for Generation of Bridging Data?
Choe, Seong-Choon;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.17, no.2, pp.119-123,
|
|
| 2 |
Guidance for the Clinical Trials Evaluation for Hypertension
Park, Hyun-Joo;Oh, Woo-Yong;Na, Han-Sung;Han, Soon-Young;Choi, Ki-Hwan;Ko, Yong-Suk;Wang, So-Young;Chung, Myeon-Woo;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.17, no.2, pp.124-138,
|
|
| 3 |
Guidance for the Clinical Trials Evaluation for Osteoarthritis
Na, Han-Sung;Park, Hyun-Joo;Oh, Woo-Yong;Han, Soon-Young;Choi, Ki-Hwan;Wang, So-Young;Chung, Myeon-Woo;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.17, no.2, pp.139-151,
|
|
| 4 |
The Revised Declaration of Helsinki and Clinical Research
Shin, Hee-Young;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.17, no.2, pp.152-163,
|
|
| 5 |
Development of Auto Coding System on the Basis of MedDRA to Analyze Adverse Events for Clinical Trial
Jeon, Eun-Jeong;Yim, Hyeon-Woo;Song, Kil-Yong;Cho, In-Young;Lee, Young-Jack;Lee, Kyoung-Shin;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.17, no.2, pp.164-173,
|
|
| 6 |
Comparative Evaluation of Pharmacokinetic Properties between Theobromine Suspension and Capsule Formulations in Healthy Volunteers
Kim, Jae-Woo;Kim, Jung-Ryul;Lim, Kyoung-Soo;Kim, Bo-Hyung;Shim, Jun-Hwa;Yoon, Seo-Hyun;Lee, Kyung-Hoon;Yu, Kyung-Sang;Shin, Sang-Goo;Jang, In-Jin;
/
Korean Society for Clinical Pharmacology and Therapeutics
, v.17, no.2, pp.174-181,
|
|